Xerion Pharmaceuticals

Xerion applies its functional proteomics platform to enable the discovery, validation, and characterization of novel disease-related protein targets in multiple disease areas.
Xerion focuses on proteins, the molecules that perform most biological functions and represent the vast majority of today's and tomorrow's drug targets. The Company has assembled and combined unique and effective technologies for drug target identification (Xcelerate™), validation (XCALIbur™) and functional site identification (X-plore™).

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Bio
- Proteins
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter: Germany

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees: 53

Turnover:

Amount:	Year:	Currency:

Year founded: 1998